Research study of an investigational medication compared to an active medication and placebo (an inactive substance) for the treatment of Generalized Anxiety Disorder.

Study Description

A randomized, double-blind, parallel-group, placebo-controlled, active-referenced, fixed-dose study comparing the efficacy and safety of 3 doses of an investigational medication in acute treatment of adults with Generalized Anxiety Disorder.

Length of study: 13 weeks

Number of office visits: 8 for most subjects

At no cost, qualified participants receive study medication and study related services. In addition there is compensation of $75 per completed visit for participation in the study.

Study inclusion/exclusion criteria

This study is only available to persons who:

• Meet criteria for Generalized Anxiety Disorder
• Can fluently read and speak English
• Are 18 to 65 years old
• Are without serious health problems
• Do not have current conditions such as Schizophrenia, Major Depression, Bipolar or Obsessive-Compulsive Disorder
• Are not addicted to drugs or alcohol
• Do not take exclusionary medications

Please contact us at:

California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd., Suite 104
Sherman Oaks, CA 91403
(818) 990-2671
bahiye@cnrmg.com